These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4673303)

  • 1. Effect of plasma kallikrein on coagulation in vitro.
    Wuepper KD; Cochrane CG
    Proc Soc Exp Biol Med; 1972 Oct; 141(1):271-6. PubMed ID: 4673303
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma prekallikrein: isolation, characterization, and mechanism of activation.
    Wuepper KD; Cochrane CG
    J Exp Med; 1972 Jan; 135(1):1-20. PubMed ID: 4536682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of commercial polyvalent proteinase inhibitors. Comparative analysis of their effect on kallikreins from different sources and trypsin].
    Iarovaia GA; Dotsenko VL; Agapova EI; Stepanian EP
    Vopr Med Khim; 1980; 26(6):832-7. PubMed ID: 6161484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of 2 -macroglobulin in bovine plasma. 3. Its actions on bovine plasma kallikrein, plasmin and thrombin.
    Sugihara H; Nagasawa S; Suzuki T
    J Biochem; 1971 Oct; 70(4):649-58. PubMed ID: 4257424
    [No Abstract]   [Full Text] [Related]  

  • 5. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glass activated kallikrein from human plasma.
    Henriques OB; Allan L
    Biochem Pharmacol; 1972 Dec; 21(23):3163-9. PubMed ID: 4650638
    [No Abstract]   [Full Text] [Related]  

  • 8. Human plasma kallikrein. Purification and preliminary characterization.
    Sampaio C; Wong SC; Shaw E
    Arch Biochem Biophys; 1974 Nov; 165(1):133-9. PubMed ID: 4474835
    [No Abstract]   [Full Text] [Related]  

  • 9. [Method for determining kallikrein of tissue origin in blood plasma and its clinical significance].
    Surovkina MS; Semenova LV; Semenov VI; Lapshina IM; Volkova TV
    Biull Eksp Biol Med; 1985 Aug; 100(8):249-52. PubMed ID: 3849314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory changes in small blood vessels induced by kallikrein (kininogenase) in the blood of Macaca mulatta infected with Plasmodium knowlesi.
    Onabanjo AO; Maegraith BG
    Ann Trop Med Parasitol; 1970 Jun; 64(2):227-36. PubMed ID: 4992593
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo interaction beween trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dog.
    Ohlsson K; Ganrot PO; Laurell CB
    Acta Chir Scand; 1971; 137(2):113-21. PubMed ID: 5149486
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro synthesis of pancreatic enzymes: effect of soybean trypsin inhibitor.
    Konijn AM; Birk Y; Guggenheim K
    Am J Physiol; 1970 Apr; 218(4):1113-7. PubMed ID: 5461613
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on prekallikrein of bovine plasma. I. Purification and properties.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1972 Mar; 71(3):471-83. PubMed ID: 5033874
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and characterization of plant inhibitors directed against plasma kallikrein and factor XII.
    Oliva ML; Sampaio MU; Sampaio CA
    Adv Exp Med Biol; 1989; 247A():467-71. PubMed ID: 2603813
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial purification of prorenin and activation by kallikreins: a possible new link between renin and kallikrein systems.
    Inagami T; Yokosawa N; Takahashi N; Takii Y
    Adv Exp Med Biol; 1979; 120B():415-28. PubMed ID: 517242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of trypsin inhibitors on blood coagulation].
    BENZER H; BLUMEL G; PIZA F
    Wien Med Wochenschr; 1960 Jul; 110():609-12. PubMed ID: 13799068
    [No Abstract]   [Full Text] [Related]  

  • 17. New aromatic diamidines with central alpha-oxyalkane or alpha, omega-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation process.
    Geratz JD; Cheng MC; Tidwell RR
    J Med Chem; 1975 May; 18(5):477-81. PubMed ID: 1171238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):11-22. PubMed ID: 4974623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma kallikrein and Hageman factor in Gram-negative bacteremia.
    Mason JW; Kleeberg U; Dolan P; Colman RW
    Ann Intern Med; 1970 Oct; 73(4):545-51. PubMed ID: 5506006
    [No Abstract]   [Full Text] [Related]  

  • 20. Crossed desensitization between plasma kallikrein and trypsin.
    Andrade SP; Feitosa MH; Guimarães JA; Rogana E; Beraldo WT
    Adv Exp Med Biol; 1986; 198 Pt B():99-104. PubMed ID: 3643745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.